Growth Metrics

Bespoke Extracts (BSPK) Common Equity (2017 - 2025)

Bespoke Extracts (BSPK) has disclosed Common Equity for 9 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • Quarterly Common Equity fell 11.42% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Sep 2025, down 11.42% year-over-year, with the annual reading at -$2.1 million for FY2024, 21.3% down from the prior year.
  • Common Equity hit -$2.6 million in Q3 2025 for Bespoke Extracts, down from -$2.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $2.0 million in Q1 2022 to a low of -$2.6 million in Q3 2025.
  • Historically, Common Equity has averaged -$930336.6 across 5 years, with a median of -$1.3 million in 2023.
  • Biggest five-year swings in Common Equity: surged 111.92% in 2021 and later tumbled 200.26% in 2023.
  • Year by year, Common Equity stood at -$79724.0 in 2021, then crashed by 743.03% to -$672096.0 in 2022, then crashed by 156.59% to -$1.7 million in 2023, then dropped by 21.3% to -$2.1 million in 2024, then dropped by 24.07% to -$2.6 million in 2025.
  • Business Quant data shows Common Equity for BSPK at -$2.6 million in Q3 2025, -$2.5 million in Q2 2025, and -$2.3 million in Q1 2025.